Surgery Partners, Inc.
Surgery Partners owns and operates surgical facilities and ancillary services through subsidiaries, serving patients, physicians and health care systems. Its Surgical Facilities segment includes ambulatory surgery centers, surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. The facilities primarily perform scheduled, non-emergency procedures across specialties including orthopedics and pain management, ophthalmology, gastroenterology and general surgery. As of December 31, 2025, Surgery Partners owned or operated 176 surgical facilities, including 157 ASCs and 19 licensed surgical hospitals. Surgery Partners earns patient service revenue from facility fees for care provided at its consolidated facilities, while non-consolidated facilities pay management fees for services such as day-to-day operations. It also develops and acquires facilities in partnership with physicians, physician groups and health care systems. Surgery Partners is headquartered in Brentwood, Tennessee.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $SGRY in the last 30 days.
See all $SGRY insider activity →Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re
HealthSpan Partners, a Bon Secours Mercy Health affiliate, raised its bid for Surgery Partners to up to $6 billion, offering $25 per share, with potential additional payments. Bain Capital, a 39% shareholder, supports the deal. Shares rose 12%. The revised offer follows a competing proposal. The deal is expected to close in Q1 2027, expanding Bon Secours' US footprint.
Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal Revised transaction with HealthSpan Partners of $25 per share, representing an enterprise value of up to approximately $6.0 billion If the transactio
Over the past 7 days, AlphAI's AI scored 16 news stories mentioning SGRY (Surgery Partners, Inc.). Coverage has skewed bullish: 13 bullish, 2 neutral, and 1 bearish.
Recent SGRY coverage spans market movers, mergers & acquisitions and corporate actions.
The amendment likely supports the stock price as the premium is clarified, but the added ticking fee and deadline uncertainty may introduce short‑term volatility.
The higher bid increases valuation expectations for Surgery Partners.
The higher cash offer and added fee increase the deal premium, likely driving the stock price up toward the $25-$26.6 range.
Earnings beat and merger news create buying pressure.
The higher offer improves deal attractiveness and may lift the stock ahead of the shareholder vote.
AlphAI scores every news story that mentions SGRY with an AI model for sentiment and relevance, and aggregates insider trades from Surgery Partners, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re
HealthSpan Partners, a Bon Secours Mercy Health affiliate, raised its bid for Surgery Partners to up to $6 billion, offering $25 per share, with potential additional payments. Bain Capital, a 39% shareholder, supports the deal. Shares rose 12%. The revised offer follows a competing proposal. The deal is expected to close in Q1 2027, expanding Bon Secours' US footprint.
Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal Revised transaction with HealthSpan Partners of $25 per share, representing an enterprise value of up to approximately $6.0 billion If the transactio
Surgery Partners (SGRY) stock rose 10% in pre-market trading after Q3 2026 earnings beat expectations, with revenue of $829M and EPS of $0.11. The company is being acquired by HealthSpan Partners for $23.50 per share, a 49% premium. Shares traded at $25.50, above the merger price and 52-week high of $23.37. The broader market and healthcare sector also gained.
Surgery Partners (SGRY) raised its merger price to $25 per share in cash, with potential additional fees. The board rejected a competing offer of $28 per share. The deal is subject to shareholder and regulatory approvals, with a closing date set for October 23, 2027.
US stock futures were mixed as investors awaited corporate earnings and the Fed's rate decision. Key deals include $63B financing for Broadcom-Anthropic and Meta's $98B share sale. Boeing reported Q3 revenue of $24.2B and a loss of $0.26 per share. Welltower raised guidance after strong Q3 results. Paccar and DoorDash-Instacart talks are also in focus.
The Nasdaq Composite rose 0.82% as AI optimism boosted tech stocks, with Anthropic's IPO filing driving gains. Surgery Partners surged 48% on takeover reports, Lumentum jumped 8% on a bullish target, while Meta fell 2% and Petrobras dropped 14%. Tesla gained over 5% after a Barclays upgrade. Investors await earnings from Microsoft and the Fed's rate decision.
Surgery Partners (SGRY) rose 48% on $6B buyout talks with Bon Secours Mercy Health. Xencor (XNCR) gained 17% on positive Phase 1 kidney cancer data. Oruka (ORKA) jumped 12% after strong Phase 2b psoriasis results. Acumen (ABOS) rose 19% ahead of November Alzheimer's trial readout.
Verizon (VZ) added 406,000 monthly phone lines in Q3, its best performance in five years. PagSeguro (PAGS) and other Brazil-linked stocks fell after Lula's election win. Surgery Partners (SGRY) is in talks for a majority stake sale to Bon Secours Mercy Health, per the Financial Times.
Nasdaq, S&P 500, and Dow Jones rise as tech sector gains on Anthropic IPO filing and cooling oil prices. Gold and 10-Year Treasury yield also up. Surgery Partners jumps 46% on acquisition news, Tesla rises after analyst upgrade, while MercadoLibre falls 10% due to election results. Meta Platforms plans $95B AI fundraising.
